Envisioning Tomorrow

Our joint ventures Syntropy™ and Athinia™ are change-makers in big data, encouraging collaboration and driving progress in the healthcare and semiconductor industries. 

Photoelectrochemical cells mimic photosynthesis to remove CO₂ more efficiently than plants, creating carbon products for easy, safe, and sustainable storage.  

We strive for the highest research ethics and welfare for all animals used in our research – and our ambition is to phase out this animal use.

Drugs that block different DNA damage repair pathways could be used alone and together with chemo-, radio- and immunotherapy to transform cancer care.

Versatile, efficient, and now stable: how advances in perovskite solar cells promise to revolutionize the semiconductor industry and lead to portable solar power.

Our new advanced 3D cell model is accelerating the search for new chemoprevention drugs that offer hope of eradicating the disease once and for all.

Lipid nanoparticles (LNPs) underpin Covid-19 mRNA vaccines and are set to transform the future of medicine by delivering cutting-edge RNA therapeutics into cells.

By bringing the power of machine learning and artificial intelligence to solve medical problems, new digital health tools promise to revolutionize remote patient care.

The 2022 Future Insight Prize winner: A dream product that draws CO₂ from the air to generate a sustainable, carbon-negative fuel source to meet our growing energy demands.

We are piloting a range of robot applications to help protect our workforce, enhance their work environment, and free up time to focus on innovation.

Tiny electrodes that record and stimulate nerve activity could help to monitor and treat a wide range of diseases.

Our new green solvents enable faster, more effective cleaning during semiconductor manufacturing, using fewer chemicals, and reducing the industry’s environmental footprint.